"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","data_processing.1","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","biomaterial:ch1","infection:ch1","sample type:ch1"
"GSM4250514","N-0379-M","GSM4250514","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250514/suppl/GSM4250514_20180725_H-miRNA-v3-2-KR_25-N-0379-M_01.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250515","N-0380-M","GSM4250515","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250515/suppl/GSM4250515_20180725_H-miRNA-v3-2-KR_26-N-0380-M_02.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250516","N-0382-M","GSM4250516","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250516/suppl/GSM4250516_20180725_H-miRNA-v3-2-KR_27-N-0382-M_03.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250517","N-0353-M","GSM4250517","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250517/suppl/GSM4250517_20180725_H-miRNA-v3-3-KR_37-N-0353-M_01.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250518","N-0356-M","GSM4250518","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250518/suppl/GSM4250518_20180725_H-miRNA-v3-3-KR_38-N-0356-M_02.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250519","N-0364-M","GSM4250519","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250519/suppl/GSM4250519_20180725_H-miRNA-v3-3-KR_39-N-0364-M_03.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250520","N-0369-M","GSM4250520","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250520/suppl/GSM4250520_20180726_H-miRNA-v3-4-KR_49-N-0369-M_01.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250521","N-0371-M","GSM4250521","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250521/suppl/GSM4250521_20180726_H-miRNA-v3-4-KR_50-N-0371-M_02.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250522","N-0374-M","GSM4250522","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: Control","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250522/suppl/GSM4250522_20180726_H-miRNA-v3-4-KR_51-N-0374-M_03.RCC.gz","828","Liquid Milk","Control","exosomes"
"GSM4250523","N-0230-M","GSM4250523","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250523/suppl/GSM4250523_20180725_H-miRNA-v3-2-KR_28-N-0230-M_04.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250524","N-0231-M","GSM4250524","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250524/suppl/GSM4250524_20180725_H-miRNA-v3-2-KR_29-N-0231-M_05.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250525","N-0232-M","GSM4250525","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250525/suppl/GSM4250525_20180725_H-miRNA-v3-2-KR_30-N-0232-M_06.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250526","N-0236-M","GSM4250526","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250526/suppl/GSM4250526_20180725_H-miRNA-v3-2-KR_31-N-0236-M_07.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250527","N-0247-M","GSM4250527","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250527/suppl/GSM4250527_20180725_H-miRNA-v3-2-KR_32-N-0247-M_08.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250528","N-0248-M","GSM4250528","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250528/suppl/GSM4250528_20180725_H-miRNA-v3-2-KR_33-N-0248-M_09.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250529","N-0249-M","GSM4250529","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250529/suppl/GSM4250529_20180725_H-miRNA-v3-2-KR_34-N-0249-M_10.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250530","N-0251-M","GSM4250530","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250530/suppl/GSM4250530_20180725_H-miRNA-v3-2-KR_35-N-0251-M_11.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250531","N-0254-M","GSM4250531","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250531/suppl/GSM4250531_20180725_H-miRNA-v3-2-KR_36-N-0254-M_12.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250532","N-0130-M","GSM4250532","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250532/suppl/GSM4250532_20180725_H-miRNA-v3-3-KR_40-N-0130-M_04.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250533","N-0138-M","GSM4250533","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250533/suppl/GSM4250533_20180725_H-miRNA-v3-3-KR_41-N-0138-M_05.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250534","N-0140-M","GSM4250534","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250534/suppl/GSM4250534_20180725_H-miRNA-v3-3-KR_42-N-0140-M_06.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250535","N-0160-M","GSM4250535","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250535/suppl/GSM4250535_20180725_H-miRNA-v3-3-KR_43-N-0160-M_07.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250536","N-0164-M","GSM4250536","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250536/suppl/GSM4250536_20180725_H-miRNA-v3-3-KR_44-N-0164-M_08.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250537","N-0178-M","GSM4250537","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250537/suppl/GSM4250537_20180725_H-miRNA-v3-3-KR_45-N-0178-M_09.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250538","N-0181-M","GSM4250538","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250538/suppl/GSM4250538_20180725_H-miRNA-v3-3-KR_46-N-0181-M_10.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250539","N-0192M","GSM4250539","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250539/suppl/GSM4250539_20180725_H-miRNA-v3-3-KR_47-N-0192M_11.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250540","N-0196-M","GSM4250540","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250540/suppl/GSM4250540_20180725_H-miRNA-v3-3-KR_48-N-0196-M_12.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250541","N-0207-M","GSM4250541","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250541/suppl/GSM4250541_20180726_H-miRNA-v3-4-KR_52-N-0207-M_04.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250542","N-0211-M","GSM4250542","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250542/suppl/GSM4250542_20180726_H-miRNA-v3-4-KR_54-N-0211-M_06.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250543","N-0222-M","GSM4250543","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250543/suppl/GSM4250543_20180726_H-miRNA-v3-4-KR_55-N-0222-M_07.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250544","N-0226-M","GSM4250544","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250544/suppl/GSM4250544_20180726_H-miRNA-v3-4-KR_56-N-0226-M_08.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250545","N-0233-M","GSM4250545","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250545/suppl/GSM4250545_20180726_H-miRNA-v3-4-KR_57-N-0233-M_09.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250546","N-0234-M","GSM4250546","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250546/suppl/GSM4250546_20180726_H-miRNA-v3-4-KR_58-N-0234-M_10.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250547","N-0238-M","GSM4250547","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250547/suppl/GSM4250547_20180726_H-miRNA-v3-4-KR_60-N-0238-M_12.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250548","N-0239-M","GSM4250548","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250548/suppl/GSM4250548_20180726_H-miRNA-v3-4-KR_62-N-0239-M_05.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
"GSM4250549","N-0240-M","GSM4250549","Public on Jan 04 2020","Jan 03 2020","Jan 04 2020","RNA","1","Human Breast Milk","Homo sapiens","biomaterial: Liquid Milk","sample type: exosomes","infection: HIV-1","total RNA","Exosomes were isolated from the skim milk supernatants using the Total Exosomes Isolation reagent (from other body fluids) as per manufacturer’s recommendations (Cat # 4484453; Thermo Fisher, Canada). Briefly, 500μl volume of each HM sample was centrifuged at 2000 x g for 10 minutes (1st spin). Without disrupting the pellet, supernatant was transferred to a new tube and centrifuged again at 10,000 x g for 30 minutes (2nd spin). The supernatant was transferred to a new tube and centrifuged at 10,000 x g for 10 minutes (3rd spin). To the clear supernatant, 500μl of 1xPBS and 500μl of exosome isolation reagent was added, vortex-mixed and incubated for 30 minutes at room temperature. After, incubation, the samples were centrifuged at 10,000 x g for 10 minutes and the supernatant was removed carefully and discarded. The exosomes in the pellets were dissolved in 50μl of exosome resuspension buffer (Cat # 4478562; Thermo Fisher, Canada), vortex-mixed and again centrifuged at 10,000 x g for 5 minutes at room temperature. Without disturbing the non-organic particulate matter in the pellet, the supernatants containing the purified HM exosomes were transferred to a new tube and stored at -20oC until further use.","Biotin","OnehundrednanogramsofexosomalRNAfromeachsample was analyzed using the NanoString nCounter SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). Brieﬂy, miRNAs were ligated to a species-speciﬁc tag sequence (nCounter miRtag) through a thermally controlled splinted ligation.","9606","Un-ligated miRtags was removed by enzymatic puriﬁcation, and the miRtagged mature miRNAs were then hybridized with the nCounter Human (V3) miRNA Expression Assay Code Set overnight at 65 °C.","Samples were then injected into the nCounter SPRINTTM cartridge and read using the nCounter® SPRINT Proﬁler (NanoString Technologies®, Inc., Seattle, WA, USA). The instrument performed the necessary magnetic bead separation, liquid transfers and immobilization of molecular labels on the sample surface before beingﬁnally analyzed by the system.","total RNA","The counts of the reporter probes were documented for each samplebythenCounterDigitalAnalyzer,whichwas subsequently analyzed using the nSolver Software (V 4.0).","Exosomal miRNA ratio analysis between groups was selected based on an arbitrary |fold change|≥1 and False Discovery Rate (FDR) ≤0.05 with all expression data represented in Log2 scale.","GPL26945","Muhammad,Atif,Zahoor","University Health Network","101 College St.","Toronto","Ontario","M5G 1L7","Canada","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM4250nnn/GSM4250549/suppl/GSM4250549_20180726_H-miRNA-v3-4-KR_63-N-0240-M_11.RCC.gz","828","Liquid Milk","HIV-1","exosomes"
